$876 Billion is the total value of ORACLE INVESTMENT MANAGEMENT INC's 30 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AXDX | New | ACCELERATE DIAGNOSTICS INC | $104,209,249,000 | – | 4,778,049 | +100.0% | 11.90% | – |
THC | New | TENET HEALTHCARE CORP | $75,172,219,000 | – | 1,755,950 | +100.0% | 8.58% | – |
RPRX | New | REPROS THERAPEUTICS INC | $22,038,863,000 | – | 1,242,326 | +100.0% | 2.52% | – |
ECYT | New | ENDOCYTE INC | $15,952,700,000 | – | 670,000 | +100.0% | 1.82% | – |
DSCI | New | DERMA SCIENCES INC | $6,340,000,000 | – | 500,000 | +100.0% | 0.72% | – |
AMRN | New | AMARIN CORP PLCspons adr new | $5,430,000,000 | – | 3,000,000 | +100.0% | 0.62% | – |
AGEN | New | AGENUS INC | $4,360,763,000 | – | 1,375,634 | +100.0% | 0.50% | – |
AGIO | New | AGIOS PHARMACEUTICALS INC | $3,915,000,000 | – | 100,000 | +100.0% | 0.45% | – |
GILD | New | GILEAD SCIENCES INC | $99,000,000 | – | 50,000 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
BIOGEN INC | 42 | Q3 2023 | 0.6% |
QUIDEL CORP | 36 | Q1 2022 | 52.5% |
AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
VERMILLION INC | 28 | Q1 2020 | 3.8% |
AGENUS INC | 25 | Q3 2023 | 9.8% |
TESARO INC | 23 | Q4 2018 | 27.8% |
ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.